To this end, the center will have an investment line with the aim of making these solutions global and able to be marketed in any geographical area where the company has operations.

These solutions will facilitate the goal of precision medicine, which, among other things, includes the development of biomarker-based treatments tailored to individual patients, offering greater potential for therapeutic efficacy with minimal toxicity. Furthermore, precision medicine can reduce the rate of treatment failure and alleviate the financial burden on healthcare systems, one of Europe's major health challenges.

The Center for Expert Solutions in IT for Precision Medicine, which is already working extensively on several real-world projects with healthcare clients, brings together a multidisciplinary team of over 20 bioinformatics professionals. These experts possess broad experience in genomic data analysis, supercomputing, AI applied to natural language processing and machine learning, among other related areas. The primary objective is to establish close collaboration with research and innovation institutions, hospitals, and healthcare professionals to ensure that the solutions are applicable and relevant in real-world settings.

According to Julio del Valle, director of the healthcare and life sciences business at Fujitsu Spain, “At Fujitsu we want to contribute to the digital transformation towards a more person-centered and M5P-oriented care model, with solutions that help improve the patient experience, involve them more in their self-care, implement precision medicine, and improve the efficiency and cybersecurity of clinical and care processes.